{
  "title": "CEO Spotlight on Allergan's Brent Saunders",
  "itunes:title": "CEO Spotlight on Allergan's Brent Saunders",
  "description": "<p>This week, Caroline Hyde sat down with Allergan Chief Executive Brent Saunders for a wide-ranging interview as part of our CEO Spotlight Series. Saunders discussed high drug prices, selling Allergan to rival AbbVie for $63 billion, why his best career decision was taking a \"huge\" pay cut and what's coming next for him after the AbbVie deal.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>This week, Caroline Hyde sat down with Allergan Chief Executive Brent Saunders for a wide-ranging interview as part of our CEO Spotlight Series. Saunders discussed high drug prices, selling Allergan to rival AbbVie for $63 billion, why his best career decision was taking a \"huge\" pay cut and what's coming next for him after the AbbVie deal.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "dfa31f8a-e5f7-11e9-99cc-1fb5df667d50",
  "omny:clipId": "4ae7100c-1e0c-4250-9327-ae3c00303f32",
  "pubDate": "Fri, 29 Nov 2019 17:00:00 +0000",
  "itunes:duration": 1992,
  "enclosure": "",
  "link": "https://omny.fm/shows/whatd-you-miss-this-week/ceo-spotlight-on-allergans-brent-saunders"
}